Point72 Hong Kong’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Sell |
17,321
-15,419
| -47% | -$561K | 0.04% | 228 |
|
|
2025
Q1 | $1.19M | Buy |
32,740
+5,341
| +19% | +$193K | 0.08% | 178 |
|
|
2024
Q4 | $1.15M | Buy |
27,399
+17,379
| +173% | +$731K | 0.07% | 173 |
|
|
2024
Q3 | $557K | Buy |
+10,020
| New | +$557K | 0.04% | 226 |
|
|
2024
Q2 | – | Sell |
-27,004
| Closed | -$1.26M | – | 674 |
|
|
2024
Q1 | $1.26M | Buy |
+27,004
| New | +$1.26M | 0.06% | 243 |
|
|
2022
Q4 | – | Sell |
-15,766
| Closed | -$653K | – | 958 |
|
|
2022
Q3 | $653K | Buy |
+15,766
| New | +$653K | 0.02% | 331 |
|
|
2022
Q1 | – | Sell |
-21
| Closed | -$2K | – | 1724 |
|
|
2021
Q4 | $2K | Sell |
21
-7,870
| -100% | -$750K | ﹤0.01% | 1236 |
|
|
2021
Q3 | $712K | Sell |
7,891
-2,209
| -22% | -$199K | 0.02% | 323 |
|
|
2021
Q2 | $963K | Buy |
+10,100
| New | +$963K | 0.03% | 286 |
|
|
2020
Q4 | – | Sell |
-688
| Closed | -$57K | – | 1565 |
|
|
2020
Q3 | $57K | Buy |
+688
| New | +$57K | 0.01% | 655 |
|
|
2019
Q4 | – | Sell |
-20
| Closed | -$1K | – | 1398 |
|
|
2019
Q3 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 915 |
|
|
2019
Q1 | – | Sell |
-23
| Closed | -$1K | – | 1231 |
|
|
2018
Q4 | $1K | Sell |
23
-43
| -65% | -$1.87K | ﹤0.01% | 809 |
|
|
2018
Q3 | $5K | Buy |
+66
| New | +$5K | ﹤0.01% | 706 |
|
|
2017
Q3 | – | Sell |
-108
| Closed | -$7K | – | 1014 |
|
|
2017
Q2 | $7K | Buy |
108
+86
| +391% | +$5.57K | 0.01% | 516 |
|
|
2017
Q1 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 680 |
|